News

Endovascular treatment of acute IVC thrombosis found effective


 

FROM THE ANNALS OF VASCULAR SURGERY

References

Endovascular treatment of acute thrombosis of the inferior vena cava is safe and effective with excellent short-term results, according to the results of a 10-year retrospective review reported by Dr. Khanjan H. Nagarsheth and his colleagues at the Staten Island University (N.Y.) Hospital.

Dr. Nagarsheth and his colleagues assessed 25 patients (44% men) with a mean age of 50.3 years, who underwent catheter-directed treatment in either the operating room or the angiography suite for acute (existing for less than 2 weeks) symptomatic IVC thrombosis (Annals Vasc Surg. 2015; 29:1373-9).

All patients had a prior history of deep vein thrombosis; 21 patients had an IVC filter at presentation.

Endovascular treatment was successful in all 25 patients. The greater majority of patients (22, 88%) received both catheter-directed thrombolysis (CDT) and pharmacomechanical thrombectomy; the remaining 3 patients received CDT alone.

Significant (greater than 50% luminal gain) angiographic resolution of the venous thromboembolism was achieved in all patients, with 23 (92%) reporting moderate to complete symptomatic improvement immediately after the procedure. At the median follow-up of 54.3 weeks, symptomatic improvement was noted in all patients, and complete symptom resolution was seen in 16 (89%). None of the IVC filters were removed and 67% of patients had a patent IVC at last follow-up.

“An aggressive endovascular approach to treatment of [acute thrombosis of the] IVC is warranted even in the presence of a thrombosed caval filter,” the authors concluded.

The authors did not indicate the existence of any conflicts.

Read the full study online in the Annals of Vascular Surgery.

mlesney@frontlinemedcom.com

Recommended Reading

Anticoagulant therapy not contraindicated in brain metastases
MDedge Cardiology
Warfarin therapy highly unpredictable in real-world practice
MDedge Cardiology
Remember ‘CURE’ indication for clopidogrel in ACS
MDedge Cardiology
Warfarin as effective as LMWH to prevent recurrent VTEs in cancer patients
MDedge Cardiology
The pros and cons of novel anticoagulants
MDedge Cardiology
ESC: Rivaroxaban safety highlighted in real-world setting
MDedge Cardiology
ESC: Too much TV boosts PE risk
MDedge Cardiology
HIT risk rises with obesity
MDedge Cardiology
Low incidence of DVT seen in routine MRI of damaged knees
MDedge Cardiology
ESC model predicts recurrent VTE risk
MDedge Cardiology